HEXO Corp. (NASDAQ:HEXO)’s share price reached a new 52-week low on Thursday . The company traded as low as $2.89 and last traded at $2.98, with a volume of 3280080 shares changing hands. The stock had previously closed at $3.70.
HEXO has been the topic of a number of research analyst reports. Zacks Investment Research lowered shares of HEXO from a “buy” rating to a “hold” rating in a research note on Thursday. Roth Capital lowered shares of HEXO from a “buy” rating to a “neutral” rating in a research note on Friday. Oppenheimer lowered shares of HEXO from an “outperform” rating to a “market perform” rating in a research note on Tuesday, June 25th. Bank of America lowered shares of HEXO from a “buy” rating to an “underperform” rating and lowered their target price for the company from $9.00 to $4.00 in a research note on Monday, October 7th. Finally, MKM Partners initiated coverage on shares of HEXO in a research note on Friday, September 20th. They issued a “buy” rating and a $12.00 target price on the stock. One investment analyst has rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the company. HEXO has an average rating of “Hold” and an average price target of $7.67.
The business’s 50 day moving average is $4.07 and its 200-day moving average is $5.45.
About HEXO (NASDAQ:HEXO)
HEXO Corp., through its subsidiary, HEXO Operations Inc, produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names.
Read More: Quantitative Easing
Receive News & Ratings for HEXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HEXO and related companies with MarketBeat.com's FREE daily email newsletter.